Myopia, commonly known as short-sightedness or near-sightedness, is one of the fastest-growing public health challenges of the 21st century. The World Health Organisation projects that 2.7 billion people will be affected by myopia by 2050, with the sharpest increase occurring in East and South Asia, including India. In urban centres like Chennai and Hyderabad, where children spend increasing amounts of time on near tasks such as reading, homework, and screen use and significantly less time outdoors than previous generations, myopia onset is occurring earlier and progression is faster than at any previous point in recorded ophthalmological history. The simple provision of glasses to correct blurred distance vision is no longer considered a sufficient clinical response to this challenge.
Myopia is not merely a refractive inconvenience requiring glasses or contact lenses. Progressive myopia, and particularly high myopia (greater than minus 6.00 dioptres), significantly increases the lifetime risk of serious, sight-threatening complications including myopic macular degeneration, retinal detachment, glaucoma, and early-onset cataract. These risks increase substantially with the degree of myopia, meaning that each additional dioptre of myopia progression represents a meaningful increase in the risk of permanent vision loss later in life. Slowing myopia progression in childhood, even by one or two dioptres, can substantially reduce lifetime risk and help preserve vision into adulthood and old age.
The major risk factors for myopia onset and progression include the amount of time a child spends on near tasks such as reading and screens, the amount of time spent outdoors (which has a well-established and consistent protective effect against myopia onset and progression in multiple population studies), the age of myopia onset (earlier onset reliably predicts faster and greater total lifetime progression), family history of myopia in one or both parents, and urban versus rural environment. In India, the combination of academically demanding school curricula, significant after-school tuition commitments, increasing screen time, and limited outdoor activity creates an environment that is highly conducive to rapid myopia progression in children.
Evidence-based myopia control strategies fall into several categories. Optical interventions include specially designed spectacle lenses and contact lenses that provide peripheral defocus signals to slow eye elongation, the primary structural mechanism of myopia progression. Pharmacological interventions include low-dose atropine eye drops, which have clinical evidence supporting a myopia-slowing effect at carefully titrated doses. Lifestyle modifications, particularly increasing daily outdoor time to at least 90 to 120 minutes, are supported by strong epidemiological evidence and are recommended as the foundation of any myopia management plan. The international standard of care for paediatric myopia now firmly includes active management rather than passive correction.
Among the optical myopia control solutions available at Caring Vision Therapy, Hoya MiYOSMART spectacle lenses represent one of the most significant clinical advances of the past decade. These lenses use Defocus Incorporated Multiple Segments (DIMS) technology, which provides clear central distance correction while simultaneously creating peripheral myopic defocus signals that slow the elongation of the eye. Clinical trials published in peer-reviewed journals demonstrated a 59 percent reduction in myopia progression over two years compared to standard single-vision lenses, with results confirmed in real-world clinical populations across multiple countries. MiYOSMART lenses are cosmetically identical to standard spectacle lenses, comfortable to wear, and suitable for everyday use by children.
At Caring Vision Therapy, myopia management begins with a comprehensive functional vision evaluation that measures current refractive status, accommodative and convergence function (both of which influence myopia progression risk), and individual risk factors for progression. The personalised myopia control programme is designed to include the most appropriate combination of interventions for the individual child, which may include MiYOSMART or other evidence-based myopia control lenses, optometric syntonics phototherapy to support visual system regulation, structured vision therapy to address accommodative and binocular function abnormalities that contribute to progression risk, and evidence-based lifestyle guidance including specific outdoor time targets and near work management recommendations.
Progress is monitored at structured intervals through the programme, and the management plan is adjusted as the child grows and as myopia status changes. Myopia control is a long-term commitment that typically continues through adolescence until myopia progression stabilises naturally, usually in the late teenage years or early adulthood. Parents should understand clearly that myopia control is not a cure for myopia and will not reverse existing short-sightedness. It is the most effective tool currently available to reduce the rate of progression and minimise the cumulative degree of myopia that the child reaches at the end of their growth period.
If your child has been diagnosed with myopia and you want to understand the options available for slowing its progression, or if you have noticed signs of blurred distance vision in your child for the first time, contact Caring Vision Therapy in Chennai or Hyderabad to schedule a myopia assessment and discuss an evidence-based management plan tailored to your child's specific risk profile and needs.
Related Reading